Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-014320

EVP, Research & CSO sold 7,900 shares at $63.74 ($503,577)

  • EVP, Research & CSO acquired 18,900 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2021-02-23 Option exercise +18,900 $1.53 $28,917 82,100 D: show line 1 in the form
Virgin Herbert EVP, Research & CSO 2021-02-23 Sale −7,900 $63.74 $503,577 74,200 D: show line 2 in the form
Open-market sales · 7,900 sh · avg $63.74 · $503,577

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Virgin Herbert EVP, Research & CSO 2021-02-23 Option exercise · Stock Option (Right to Buy) −18,900 353,355 D: show line 3 in the form
Loading xslF345X03/doc4.xml…